<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Initial treatment of Waldenström macroglobulinemia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Initial treatment of Waldenström macroglobulinemia</h1>
<div class="graphic"><div class="figure"><div class="ttl">Initial treatment of Waldenström macroglobulinemia</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm describes our preferred management of patients with newly diagnosed WM. There are other acceptable approaches. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.</div><div class="graphic_footnotes">WM: Waldenström macroglobulinemia; BTK: Bruton tyrosine kinase.<br/>* Indications for treatment:

<ul>
<li>Recurrent fever, night sweats, weight loss, fatigue</li>
<li>Hyperviscosity</li>
<li>Lymphadenopathy that is either symptomatic or bulky</li>
<li>Symptomatic hepatomegaly and/or splenomegaly</li>
<li>Symptomatic organomegaly and/or organ or tissue infiltration</li>
<li>Peripheral neuropathy due to WM</li>
<li>Symptomatic cryoglobulinemia</li>
<li>Cold agglutinin hemolytic anemia</li>
<li>Immune hemolytic anemia and/or thrombocytopenia</li>
<li>Nephropathy related to WM</li>
<li>Amyloidosis related to WM</li>
<li>Hemoglobin of 10 g/dL or less</li>
<li>Platelet count of 100 × 10<sup>9</sup>/L or less</li>
</ul>

¶ Symptoms of hyperviscosity include oronasal bleeding, blurred vision, headaches, dizziness, paresthesias, retinal vein engorgement and/or flame-shaped hemorrhages, papilledema, stupor or coma.<br/>Δ Continuous therapy with a BTK inhibitor is an acceptable alternative for patients who decline chemotherapy.</div><div id="graphicVersion">Graphic 97649 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
